Literature DB >> 30125150

Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.

Shuji Ogino1,2,3,4, Jonathan A Nowak1, Tsuyoshi Hamada2, Danny A Milner5, Reiko Nishihara1,3,4,6.   

Abstract

Evidence indicates that diet, nutrition, lifestyle, the environment, the microbiome, and other exogenous factors have pathogenic roles and also influence the genome, epigenome, transcriptome, proteome, and metabolome of tumor and nonneoplastic cells, including immune cells. With the need for big-data research, pathology must transform to integrate data science fields, including epidemiology, biostatistics, and bioinformatics. The research framework of molecular pathological epidemiology (MPE) demonstrates the strengths of such an interdisciplinary integration, having been used to study breast, lung, prostate, and colorectal cancers. The MPE research paradigm not only can provide novel insights into interactions among environment, tumor, and host but also opens new research frontiers. New developments-such as computational digital pathology, systems biology, artificial intelligence, and in vivo pathology technologies-will further transform pathology and MPE. Although it is necessary to address the rarity of transdisciplinary education and training programs, MPE provides an exemplary model of integrative scientific approaches and contributes to advancements in precision medicine, therapy, and prevention.

Entities:  

Keywords:  causal inference; exposome; genomics; immunity; public health; translational research

Mesh:

Year:  2018        PMID: 30125150      PMCID: PMC6345592          DOI: 10.1146/annurev-pathmechdis-012418-012818

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  147 in total

1.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

Authors:  Mara Roxana Rubinstein; Xiaowei Wang; Wendy Liu; Yujun Hao; Guifang Cai; Yiping W Han
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

Review 2.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

3.  The Role of Prostaglandin E(2) in Tumor-Associated Immunosuppression.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  Trends Mol Med       Date:  2015-12-17       Impact factor: 11.951

Review 4.  Chasing the personalized medicine dream through biomarker validation in colorectal cancer.

Authors:  Harshali Patil; Shailaja Gada Saxena; Colin J Barrow; Jagat R Kanwar; Arnab Kapat; Rupinder K Kanwar
Journal:  Drug Discov Today       Date:  2016-09-28       Impact factor: 7.851

Review 5.  Dietary intake of n-3 fatty acids and colorectal cancer risk: a meta-analysis of data from 489 000 individuals.

Authors:  Xiao-Jian Shen; Jun-Dong Zhou; Jia-Yi Dong; Wei-Qun Ding; Jin-Chang Wu
Journal:  Br J Nutr       Date:  2012-08-20       Impact factor: 3.718

6.  SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.

Authors:  Joice Kuroiwa-Trzmielina; Fan Wang; Robert W Rapkins; Robyn L Ward; Daniel D Buchanan; Aung Ko Win; Mark Clendenning; Christophe Rosty; Melissa C Southey; Ingrid M Winship; John L Hopper; Mark A Jenkins; Jake Olivier; Nicholas J Hawkins; Megan P Hitchins
Journal:  Clin Cancer Res       Date:  2016-06-07       Impact factor: 12.531

7.  Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.

Authors:  Enric Domingo; David N Church; Oliver Sieber; Rajarajan Ramamoorthy; Yoko Yanagisawa; Elaine Johnstone; Brian Davidson; David J Kerr; Ian P M Tomlinson; Rachel Midgley
Journal:  J Clin Oncol       Date:  2013-09-23       Impact factor: 44.544

8.  Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota.

Authors:  Aaron C Ericsson; Sadia Akter; Marina M Hanson; Susheel B Busi; Taybor W Parker; Rebecca J Schehr; Miriam A Hankins; Carin E Ahner; Justin W Davis; Craig L Franklin; James M Amos-Landgraf; Elizabeth C Bryda
Journal:  Oncotarget       Date:  2015-10-20

Review 9.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Authors:  Shuji Ogino; Paul Lochhead; Andrew T Chan; Reiko Nishihara; Eunyoung Cho; Brian M Wolpin; Jeffrey A Meyerhardt; Alexander Meissner; Eva S Schernhammer; Charles S Fuchs; Edward Giovannucci
Journal:  Mod Pathol       Date:  2013-01-11       Impact factor: 7.842

10.  Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.

Authors:  Shuji Ogino; Iny Jhun; Douglas A Mata; Thing Rinda Soong; Tsuyoshi Hamada; Li Liu; Reiko Nishihara; Marios Giannakis; Yin Cao; JoAnn E Manson; Jonathan A Nowak; Andrew T Chan
Journal:  NPJ Precis Oncol       Date:  2017-12-06
View more
  76 in total

Review 1.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

2.  Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer.

Authors:  Kota Arima; Mai Chan Lau; Melissa Zhao; Koichiro Haruki; Jonathan A Nowak; Marios Giannakis; Charles S Fuchs; Shuji Ogino; Keisuke Kosumi; Kosuke Mima; Mancang Gu; Juha P Väyrynen; Tyler S Twombly; Yoshifumi Baba; Kenji Fujiyoshi; Junko Kishikawa; Chunguang Guo; Hideo Baba; William G Richards; Andrew T Chan; Reiko Nishihara; Jeffrey A Meyerhardt
Journal:  Mol Cancer Res       Date:  2020-03-12       Impact factor: 5.852

3.  Shuji Ogino: a critical mass of pathological epidemiologists is needed for transdisciplinary studies.

Authors:  Brad Li
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-04

Review 4.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

Review 5.  Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer.

Authors:  Lorena Losi; Tommaso Zanocco-Marani; Alexis Grande
Journal:  Histol Histopathol       Date:  2020-06-22       Impact factor: 2.303

6.  Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections.

Authors:  Juha P Väyrynen; Mai Chan Lau; Koichiro Haruki; Sara A Väyrynen; Jeffrey A Meyerhardt; Marios Giannakis; Shuji Ogino; Jonathan A Nowak; Andressa Dias Costa; Jennifer Borowsky; Melissa Zhao; Kenji Fujiyoshi; Kota Arima; Tyler S Twombly; Junko Kishikawa; Simeng Gu; Saina Aminmozaffari; Shanshan Shi; Yoshifumi Baba; Naohiko Akimoto; Tomotaka Ugai; Annacarolina Da Silva; Mingyang Song; Kana Wu; Andrew T Chan; Reiko Nishihara; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2020-05-21       Impact factor: 12.531

7.  Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.

Authors:  Peter T Campbell; Christine B Ambrosone; Timothy R Rebbeck; Shuji Ogino; Reiko Nishihara; Hugo J W L Aerts; Melissa Bondy; Nilanjan Chatterjee; Montserrat Garcia-Closas; Marios Giannakis; Jeffrey A Golden; Yujing J Heng; N Sertac Kip; Jill Koshiol; X Shirley Liu; Camila M Lopes-Ramos; Lorelei A Mucci; Jonathan A Nowak; Amanda I Phipps; John Quackenbush; Robert E Schoen; Lynette M Sholl; Rulla M Tamimi; Molin Wang; Matty P Weijenberg; Catherine J Wu; Kana Wu; Song Yao; Kun-Hsing Yu; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2019-05-08       Impact factor: 2.506

8.  Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology.

Authors:  Keisuke Kosumi; Kosuke Mima; Hideo Baba; Shuji Ogino
Journal:  J Lab Precis Med       Date:  2018-09-25

9.  Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.

Authors:  Koichiro Haruki; Keisuke Kosumi; Tsuyoshi Hamada; Tyler S Twombly; Juha P Väyrynen; Sun A Kim; Yohei Masugi; Zhi Rong Qian; Kosuke Mima; Yoshifumi Baba; Annacarolina da Silva; Jennifer Borowsky; Kota Arima; Kenji Fujiyoshi; Mai Chan Lau; Peilong Li; Chunguang Guo; Yang Chen; Mingyang Song; Jonathan A Nowak; Reiko Nishihara; Katsuhiko Yanaga; Xuehong Zhang; Kana Wu; Susan Bullman; Wendy S Garrett; Curtis Huttenhower; Jeffrey A Meyerhardt; Marios Giannakis; Andrew T Chan; Charles S Fuchs; Shuji Ogino
Journal:  J Pathol       Date:  2020-02-03       Impact factor: 7.996

10.  Night-Shift Work Duration and Risk of Colorectal Cancer According to IRS1 and IRS2 Expression.

Authors:  Yan Shi; Li Liu; Eva S Schernhammer; Reiko Nishihara; Xuehong Zhang; Tsuyoshi Hamada; Jonathan A Nowak; Marios Giannakis; Yanan Ma; Mingyang Song; Daniel Nevo; Keisuke Kosumi; Mancang Gu; Sun A Kim; Teppei Morikawa; Kana Wu; Jing Sui; Kyriaki Papantoniou; Molin Wang; Andrew T Chan; Charles S Fuchs; Jeffrey A Meyerhardt; Edward Giovannucci; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.